<DOC>
	<DOC>NCT02538874</DOC>
	<brief_summary>The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.</brief_summary>
	<brief_title>A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body</brief_title>
	<detailed_description />
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Age 21 to 55 years (Part A,B, and C) BMI 3040 (Part A or Part B); BMI 2035 (Part C). BMI = weight (kg)/ [height (m)] Any significant medical illness Cannot tolerate subcutaneous injections, or having blood samples taken Smoking more than 10 cigarettes/day History of allergy to pegylated compounds or of hypersensitivity to protein based therapeutics. HIV, Hepatitis B virus (HBV) or Hepatitis C virus (HCV) infection. Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>